Physician profile
Jay J Rubin
NPI 1649294448
$990.02
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $301.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $198.97 | 2019 | |
| Sk Life Science, INC. | $123.27 | 2020 | |
| Acadia Pharmaceuticals INC | $103.03 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $76.68 | 2019-2020 | |
| Eisai INC. | $72.29 | 2019 | |
| Lilly USA, LLC | $66.81 | 2019-2020 | |
| Mdd US Operations, LLC | $54.59 | 2019-2020 | |
| Acorda Therapeutics, INC | $48.21 | 2019-2020 | |
| Grifols USA, LLC | $37.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.33 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $31.18 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $26.66 | 2019 | |
| Alnylam Pharmaceuticals INC. | $25.72 | 2020 | |
| Ge Healthcare | $25.08 | 2019 | |
| Avanir Pharmaceuticals, INC. | $19.88 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $17.34 | 2019 | |
| Si-Bone, INC. | $15.28 | 2019 | |
| Nevro Corp. | $14.12 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Research and ownership
$19,394,281.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.